£735K
The oversubscribed round was backed by Consilience Ventures, SOSV, and Catapult Ventures to support the development of the GRACE device.
"This investment is a vote of confidence in QV Bioelectronics from sector-expert investors. The funds raised will fuel the next phase of development of the GRACE device, allowing the size of the QV Bioelectronics team to grow in the process. This will take our innovative electric field therapy technology a few steps closer towards the clinic."
